NDC 71858-0025 – Tirosint
Levothyroxine Sodium 88 ug/1 · Capsule · Oral
Product NDC71858-0025
Product details
- Brand name
- Tirosint
- Generic name
- Levothyroxine sodium
- Labeler
- IBSA Pharma Inc.
- Dosage form
- Capsule
- Route
- Oral
- Marketing category
- NDA · NDA021924
- Marketed since
- December 1, 2018
- Listing expires
- December 31, 2027
- Pharmacologic class
- l-Thyroxine
Active ingredients
- Levothyroxine Sodium 88 ug/1
Package NDC codes (2)
| Package NDC | Description | Since |
|---|---|---|
| 71858-0025-2 sample | 3 BLISTER PACK in 1 CARTON (71858-0025-2) / 10 CAPSULE in 1 BLISTER PACK | Aug 24, 2025 |
| 71858-0025-4 | 3 BLISTER PACK in 1 CARTON (71858-0025-4) / 10 CAPSULE in 1 BLISTER PACK | Dec 1, 2018 |
Recalls mentioning this NDC
- D-0495-2021 Jun 2, 2021 · Class II
CGMP Deviations: Intermittent exposure to temperature excursion during storage.
Other Tirosint products
- 71858-0005 Levothyroxine Sodium 13 ug/1 · Capsule · IBSA Pharma Inc.
- 71858-0010 Levothyroxine Sodium 25 ug/1 · Capsule · IBSA Pharma Inc.
- 71858-0012 Levothyroxine Sodium 37.5 ug/1 · Capsule · IBSA Pharma Inc.
- 71858-0013 Levothyroxine Sodium 44 ug/1 · Capsule · IBSA Pharma Inc.
- 71858-0015 Levothyroxine Sodium 50 ug/1 · Capsule · IBSA Pharma Inc.
- 71858-0017 Levothyroxine Sodium 62.5 ug/1 · Capsule · IBSA Pharma Inc.
- 71858-0020 Levothyroxine Sodium 75 ug/1 · Capsule · IBSA Pharma Inc.
- 71858-0030 Levothyroxine Sodium 100 ug/1 · Capsule · IBSA Pharma Inc.
- 71858-0035 Levothyroxine Sodium 112 ug/1 · Capsule · IBSA Pharma Inc.
- 71858-0040 Levothyroxine Sodium 125 ug/1 · Capsule · IBSA Pharma Inc.
- 71858-0045 Levothyroxine Sodium 137 ug/1 · Capsule · IBSA Pharma Inc.
- 71858-0050 Levothyroxine Sodium 150 ug/1 · Capsule · IBSA Pharma Inc.